Injecto Polymers Ltd

Injecto Polymers Ltd has announced that its Board of Directors will convene on November 11, 2026, to consider and approve the unaudited financial results for the half-yearly period ending September 30, 2026. The meeting will also review the utilization of IPO proceeds, statement of deviation(s) or variation(s) under SEBI LODR Regulations, the Monitoring Agency Report, and statutory compliance filings. The trading window will remain closed from October 1, 2026, to November 13, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations.

Injecto Polymers Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from Thursday, 1st October, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results for the half-year ended 30th September, 2026. The decision is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The date of the Board Meeting to consider these financial results will be communicated separately.

Craft Emerging Market Fund PCC, through its associated entities, has acquired a 5.75% stake in Injecto Polymers Limited via open market transactions. The acquisition amounts to 1,196,400 shares out of a total of 20,789,600 shares. This substantial acquisition triggers disclosure requirements under SEBI's Takeover Regulations. The transaction was completed through open market purchases, with the final acquisition date or intimation receipt date being September 18, 2026.

Capital Square Financial Services Pvt Ltd, acting as a market maker, has increased its shareholding in Injecto Polymers Limited. The acquisition involved 958,800 equity shares, representing 4.61% of the equity share capital, purchased via open market transactions on September 21, 2026. This brings their total holding to 1,242,000 equity shares, or 5.97% of the total equity share capital. The company's total equity share capital is valued at ₹207.89 crore, divided into 20,789,600 equity shares of ₹10 each.